ILYANG PHARMACEUTICAL CO.,LTD

Andere talen Ilyang Pharmaceutical Co.,Ltd

Aandelen

A007570

KR7007570005

slotkoers Korea S.E. Andere beurzen 00:00:00 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
13.920 ^KRW	+0,07%		+0,94%	-11,05%

2023	Ilyang Pharmaceutical Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2023	CI
2023	Ilyang Pharmaceutical Co.,Ltd (KOSE:A007570) kondigt een aandeleninkoop aan ter waarde van 2.000 miljoen KRW.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.	10-10-23
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on April 6, 2023, has expired with 115,080 shares, representing 0.63% for KRW 1,999.72 million.	10-10-23
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on April 6, 2023.	13-07-23
Ilyang Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 2,000 million worth of its shares.	06-04-23
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	06-04-23
Tranche Update on Ilyang Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on March 10, 2022.	08-09-22
Ilyang Pharmaceutical Co.,Ltd's Equity Buyback announced on March 10, 2022, has expired with 118,321 shares, representing 0.65% for KRW 2,859.89 million.	08-09-22
Eight South Korean Firms to Donate $2.4 Million Worth of Medicine to Ukraine	12-04-22
Ilyang Pharmaceutical Co.,Ltd announces an Equity Buyback for KRW 3,000 million worth of its shares.	10-03-22
Ilyang Pharmaceutical Co.,Ltd authorizes a Buyback Plan.	10-03-22
Ilyang Pharmaceutical Co.,Ltd(KOSE:A007570) dropped from KOSPI 200 Index	09-12-21
Boryung Pharmaceutical : S.Korea sticks to flu vaccine plan despite safety fears after 25 die	22-10-20
Boryung Pharmaceutical : Number of South Koreans dying after flu shot rises, prompts vaccine worries	22-10-20
Il-Yang Pharmaceutical Signs Licence with Laboratorios Biopas to Export Leukemia Drug Supect to Colombia	05-09-16
Ilyang Pharmaceutical Co., Ltd announced that it has received KRW 30 billion in funding from Hana Daetoo Securities Co., Ltd., Investment Arm, Hanyang Securities Co. Ltd., Investment Arm, Hungkuk Life Insurance Co., Ltd., Korea Securities Finance Corporation, Investment Arm, KTB Investment & Securities Co.,Ltd., and SBI Savings Bank Inc., Investment Arm.	13-06-14
Ilyang Pharmaceutical Co., Ltd announced that it expects to receive KRW 30 billion in funding from Hana Daetoo Securities Co., Ltd., Investment Arm, Hanyang Securities Co. Ltd., Investment Arm, Hungkuk Life Insurance Co., Ltd., Korea Securities Finance Corporation, Investment Arm, KTB Private Equity, and SBI Savings Bank Inc., Investment Arm.	12-06-14
Ilyang Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till September 25, 2022.	18-09-12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Alle transcripties over 9000 bedrijven, de dag van publicatie!

Krijg nu toegang!

fermer